Endoscopy Procedures Estimates Market

Global Endoscopy Procedures Estimates Industry Outlook (2022-2032)

The global endoscopy procedures estimates market was valued at US$ 223 Mn in 2021, and is expected to gain a significant position in the market with a steady CAGR rate of 1.5% during the forecast period, 2022- 2032. The industry is projected to reach a market size of worth US$ 263 Mn by 2032.

Report Attributes	Details
Market Value for 2021	US$ 223 Mn
Expected Market Size in 2022	US$ 227 Mn
Projected Market Valued in 2032	US$ 263 Mn
Growth Rate (2022-2032)	1.5% CAGR
Market Share of APAC during 2022	44%
Revenue Share of Gastroscopy	32%
Key Companies Profiled	China Resources Phoenix Healthcare Holdings Company Limited Tenet Healthcare Corporation Surgical Care Affiliates AMSURG Corporation Ramsay Health Care Apollo Hospitals Enterprise Ltd IHH Healthcare Berhad

By the end of 2022, this market is poised at achieving a global market valuation of US$ 263 Mn. As chronic diseases are more prevalent, minimally invasive endoscopic surgeries are increasingly used to diagnose, treat, and prevent the internal organ complications associated with these conditions. National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) statistics report that nearly six in ten American adults suffer from a chronic disease. Further, the rapid adoption of minimally invasive procedures by healthcare providers is expected to lead to a rise in endoscopic procedures. 

Demand Analysis of Endoscopy Procedures Estimates 2015-2021 vs. Market Outlook 2022-2032

From 2015-2021, demand for endoscopy procedures estimates expanded at around 2.5% CAGR. It is expected that the number of endoscopic procedures will rise as the preference for minimally invasive surgery increases. Globally, the increasing number of surgeries is also expected to boost the market growth in the forecast years. In the United States and Europe, over 40 to 50 million major medical procedures are performed each year, according to a study published in the International Journal of Surgery. Furthermore, with the growing incidence of stomach, esophageal, and colon cancers, endoscopic surgeries are expected to increase over the forecast period.

Global endoscopy procedure estimates decreased by 46% between 2019 and 2021. The COVID-19 pandemic has reduced the adoption of endoscopic procedures in 2021 when compared to 2019. The drop in surgeries is attributed to the government's recommendation to cancel all elective surgeries. Moreover, there was a shortage of healthcare professionals in major geographic regions, resulting in decreased endoscopy procedures at the end of 2020.

Over the next 10 years, the procedure is expected to grow by approximately 2% to 3% per year. Throughout the forecast period, two major factors are expected to accelerate the adoption of endoscopic surgeries: the growing number of cancers and gastrointestinal disorders, and the growing preference for minimally invasive procedures. The technological advancements and growing burden of chronic non-communicable diseases across the globe are expected to increase the number of endoscopic procedures performed after COVID. According to the WHO, about 71% of all deaths occur each year as a result of non-communicable diseases.

What are the Specific Drivers of the Endoscopy Procedures Estimates Market?

Demand for Minimally Invasive Surgery will bolster the growth

The growing preference for minimally invasive surgery over conventional methods will also lead to more endoscopic surgeries. Over the forecast years, global market growth is expected to be boosted by the increasing number of surgeries performed. In addition to being less invasive, minimally invasive surgery is safer. It is performed using procedures with smaller incisions, that results in less trauma to the body and less blood loss.

Secondly, the scarring after such a procedure is reduced. Globally, there are over 310 million major medical procedures performed each year, of which over 40 to 50 million are performed in the U.S. and over 20 million in Europe, according to data published in the International Journal of Surgery.

Increasing Incidences of chronic diseases to accelerate the Market Growth

Over the forecast period, the increasing incidence of stomach, esophageal, and colon cancers is forecast to drive the demand for endoscopic surgery. According to the Globocan 2021 report, there were respectively 1.9, 1.1, and 0.6 million new cases of cancer in the colorectum, stomach, and esophagus.

In order to diagnose collateral and gastric cancer, over six to eight endoscopic biopsies are recommended, which is driving the adoption of endoscopic procedures further.

Technological Innovations to propel Market Growth

Market growth will be fueled by developments in endoscopic devices that yield high-quality images of the digestive tract, as well as the development of new, cost-effective devices. In 2019, Fujifilm launched 10 new endoscopes to strengthen its offer in interventional gastro-intestinal and interventional pulmonary endoscopy with advanced features such as Ultra-Slim, compactability, and removable single-use end caps for manual cleaning.

Due to the increasing prevalence of diseases requiring endoscopic diagnosis, the endoscopes segment value in 2020 was over USD 12,400 million. Due to technological advancements in the endoscopes used for early detection of diseases such as cancer, infections, and malignancies, endoscopes are seeing massive demand. Also, endoscopes are in high demand since they are minimally invasive devices, have improved ergonomics, safety, and efficacy.

Country-wise-Analysis

How will the market emerge in the APAC region during the forecast period?

In 2022, Asia Pacific is expected to hold 44% revenue in the market for endoscopy procedures estimates as of 2022. Endoscopic procedures in this region are highly adopted due to the high prevalence of digestive tract disorders and a larger population.

A growing number of modern healthcare facilities, as well as increased awareness about minimally invasive surgery, will also contribute to the increased adoption of endoscopic procedures within this region. 

What will be the Growth Outlook in North America?

By 2032, the North American market is expected to account for the second-highest share of endoscopic procedures, growing at a CAGR of 4%. The high prevalence of endoscopic surgeries and the widespread use of minimally invasive endoscopic surgery will contribute to the region's growth.

A rise in functional gastrointestinal disorders as well as irritable bowel syndrome will also contribute to the growth of the region. For example, according to the International Foundation for Gastrointestinal Disorders Statistics, Irritable Bowel Syndrome (IBS) is the most common gastrointestinal disorder in the United States, with between 2.4 and 3.5 million physician visits a year for the diagnosis and treatment of the disorder.

Category-wise Insights

What can be expected from the Gastroscopy Segment during the forecast period?

In terms of procedures, the gastroscopy segment is expected to dominate the market in 2022 with a 32% share. This segment has the greatest share due to the increasing number of endoscopic surgeries performed for diagnosis of digestive tract diseases or illnesses of the esophagus.

The segment is also anticipated to grow as the demand for upper endoscopy surgery for patients with cirrhosis of the liver increases. Growth of this segment is further attributed to the fact that gastroscopy is recommended by physicians in order to diagnose several common symptoms, such as indigestion, abdominal pain, dysphagia, excessive vomiting, unusual burping, and so on. Additionally, the growing prevalence of digestion and swallowing disorders drives the growth of this segment. Approximately 15 million Americans suffer from swallowing difficulties, according to the National Foundation of Swallowing Disorders.

Competitive Landscape

Due to the presence of several major players, the market is highly competitive and fragmented. Companies are undertaking various strategic initiatives to recover losses resulting from the pandemic and to strengthen their market positions. Additionally, these companies make investments that allow them to hold a large share of the market.

Endoscopy Procedures Market Report Scope

Attributes	Details
Forecast Period	2022- 2032
Historical Data Available For	2015- 2021
Market Analysis	US$ Mn for Value & ‘000 Units for Volume
Key Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Key countries covered	U.S. Canada U.K. Germany France Italy BENELUX Nordics Japan China South Korea Brazil Mexico GCC Turkey South Africa
Key Segments Covered	Application Region

Key Segments Covered in the Endoscopy Procedures Estimates Industry Survey

• By Application :

  • Colonoscopy
  • Gastrointestinal (GI) Endoscopy
  • Laparoscopy
  • Bronchoscopy
  • Gastroscopy
  • Duodenoscopy
  • Cystoscopy